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Background: The crucial role of physicians in tobacco control (TC) is widely recognized. In 2008, Portugal
implemented a non-comprehensive smoke-free policy (SFP). In 2009, a conference-survey was carried out to explore
Portuguese physicians’ engagement in tobacco control, by evaluating the following: 1) attendance at TC training
and awareness of training needs; 2) participation in TC activities; 3) attitudes and beliefs regarding SFPs.
Methods: Questionnaire-based cross-sectional study conducted during two major national medical conferences
targeting GPs, hospitalists, and students/recent graduates. Descriptive analysis and logistic regression were performed.
Results: Response rate was 63.7% (605/950). Of the 605 participants, 58.3% were GPs, 32.4% hospitalists, 9.3%
others; 62.6% were female; mean age was 39.0 ± 12.9 years. Smoking prevalence was 29.2% (95% CI: 23.3-35.1) in
males; 15.8% (95% CI: 12.1-19.5) in females, p < 0.001. While the overwhelming majority of physicians strongly
agreed that second-hand smoke (SHS) endangers health, awareness of SFP benefits and TC law was limited, p < 0.001. A
significant minority (35.5%) believed that SHS can be eliminated by ventilation systems. Most physicians lacked training;
only a minority (9.0%) participated regularly in TC. Training was the most consistent predictor of participation in
TC. General agreement with SFP was high; but significantly lower for indoor leisure settings, outdoors bans in
healthcare/schools settings and smoking restrictions in the home/car, p < 0.001. Smoking behaviour strongly
predicted support for smoking restrictions in restaurants and bars/discos, healthcare outdoors and private
settings.
Conclusions: The findings suggest that Portuguese physicians are not aware of their role in tobacco control.
Poor engagement of physicians in TC may contribute to the current lack of comprehensive policies in Portugal
and Europe and undermine social norm change. Medical and professional continuing education on tobacco
control should be made top priorities.
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The tobacco epidemic continues to expand globally and
remains a leading cause of morbidity and premature death
[1]. The World Health Organization (WHO) estimates
that tobacco use and exposure to second-hand smoke
(SHS) will cause over 8 million deaths in 2030 unless ur-
gent action is taken [2]. Tobacco remains, however, the
most readily preventable cause of death. In order to curb
the pandemic, WHO recommends the implementation of
comprehensive tobacco control (TC) policies, including* Correspondence: sbravara@fcsaude.ubi.pt
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unless otherwise stated.price policies, and smoke-free policies (SFPs); bans on to-
bacco advertising, promotion and sponsorship; health
education on the hazards of tobacco use and access to to-
bacco dependence treatment; regulation of tobacco prod-
ucts and other evidence-based interventions. These are
based on the WHO Framework Convention on Tobacco
Control (WHO-FCTC) [2]. Currently, all EU countries
have ratified the WHO-FCTC. Despite this commitment,
most European countries have failed to implement com-
prehensive policies due to tobacco industry interference in
policy-making and inconsistent advocacy; underfunding
and poor enforcement of TC policies [3-6].
In fact, TC progress remains deadly slow in several
European countries such as Portugal [3,6]. In JanuaryLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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and poorly-enforced smoke-free policy (SFP) was imple-
mented disregarding FCTC guidelines. Many exemptions
apply, particularly in hospitality venues, and frequent
breaches have been reported [8,9]. The role of health-
care professionals (HCPs) and its organizations has
been highlighted by the WHO. Among HCPs, TC efforts
should discourage tobacco use, disseminate TC training
and promote smoke-free environments and other evidence-
based strategies. Similarly, physicians should publicly lead
TC advocacy and monitor policy impact over time [10,11].
The roles of physicians as both exemplars and leaders are,
moreover, crucial to the TC movement and to social norm
change. Note too that TC progress has been greater in
countries where few physicians smoke and their commit-
ment to public health policy is strongest [10,12]. Given this
evidence, physicians’ TC awareness and training should be
top priorities. Although this matter is a TC and a research
relevant goal, knowledge gaps persist. This may be partially
explained by the fact that surveying physicians is particu-
larly challenging. In survey research, physicians have been
appointed as a professional group from which it is difficult
to obtain collaboration. Low response rates reduce sample
size and can allow non-response bias and uncertainty
regarding the survey findings [13,14]. Several authors
have consistently reported low response rates when
surveying Portuguese physicians’ smoking behaviour
and TC attitudes and practices [15-18]. The Portuguese
tobacco law highlights the need to engage all HCPs,
and particularly physicians, with TC activities, including
training [7]. To date, little information is available con-
cerning this requirement’s implementation. In 2009, a
conference-survey was carried out to explore Portuguese
physicians’ smoking behaviour trends and their engage-
ment in tobacco control [19]. The purpose of the present
study was to explore Portuguese physicians’ engagement
in TC, by evaluating the following issues: 1) attendance at
TC training and awareness of training needs; 2) participa-
tion in TC activities; 3) attitudes and beliefs regarding
SFPs/SHS; and support for comprehensive SFPs. Add-
itionally, the study aimed to identify factors associated
with physicians’ participation in TC and their support for
comprehensive SFPs.
Methods
Study design, study population, site and sampling, ethical
approval
This was an exploratory cross-sectional study, conducted in
2009 during two major national medical conferences using
a purposive-sampling procedure, and following Nardini et
al’s methodology [20]. All data were self-reported. Self-
administered questionnaires were delivered and collected
during conferences targeting general practionners (GPs),
hospital-based physicians or hospitalists, and undergraduatemedical students and recent-graduates (SRGs). These con-
ferences were the following:
1. Portuguese Stroke Society Annual Conference where
questionnaires were distributed to all registered
physicians (n = 450);
2. Portuguese GP Society Annual Conference where
questionnaires were distributed to a systematic
random sample of the attendees (33% out of 1500;
n = 500).
GPs should be more engaged with tobacco control ac-
tivities, according to national and international guide-
lines [7,21]. In order to contrast GPs with hospital-based
physicians, and to include physicians from all over the
country with a wide range of age and professional devel-
opment, this setting was selected. The theoretical sample
size was 500 physicians assuming an expected smoking
prevalence of 22.0% [22], with a 95% confidence interval
(CI) and a precision of 3.6%. A total of 950 question-
naires were delivered, assuming an expected response
rate of 60% [20]. The questionnaire included a cover let-
ter explaining the study’s aims, the institutions involved,
the researchers’ contact details and guarantees as to ano-
nymity. Approval for the survey implementation was ob-
tained from both conferences board committees. The
organizing committees were previously contacted, in
order to sound about the characteristics of attendees
(number, specialty, and region). The study was approved
by the Beira Interior University-Hospital Research Ethics
Committee.
Questionnaire and measures
Physicians’ beliefs and attitudes to SFP were the main
outcomes, as those measures are strongly associated
with tobacco social norms [23]. Additionally, physicians’
participation in TC was assessed. A validated question-
naire was adapted [16]. Additional items were developed
addressing TC attitudes and beliefs and pilot tested
among a small group of GPs, hospitalists and SRGs. The
questionnaire collected standard information on socio-
demographics and specialty. The second part of the
questionnaire explored smoking behaviour, attitudes to
being role-models (RMs) as non-smokers (RM attitudes)
and smoking in private settings. The third part ad-
dressed TC practices, attitudes and beliefs, and training
in smoking prevention/treatment. Smoking status was
self-reported and categorized according to WHO guide-
lines for tobacco use [24]. Smoking in private settings
was assessed by the following questions: Do you usually
smoke 1) in the home 2) in the car? Answer: never (0);
yes, only at an open window (1); yes, sometimes (1); yes
regularly (1). Specific training in smoking prevention/ces-
sation was assessed as undergraduate (UGT) or graduate
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12 h; >12 h). Physicians’ TC practices were assessed
by the following question: Do you participate in or
have you ever participated in 1) smoking prevention/
TC activities 2) smoking cessation activities? Answer:
regularly (1); occasionally (1); never (0). Response cat-
egories were re-coded and dichotomized into “no” (0)
and “yes” (1). TC attitudes and beliefs were assessed by
four items:
1. Awareness of training needs. Question: Do you
consider that you need specific training in smoking
prevention/treatment?
2. SHS and SFP beliefs. The wording of questions is
shown in the Results section (see tables).
3. Smoking restrictions in private settings. Questions:
Do you allow smoking 1) in your home 2) in your
car?
4. Support for SFP in public settings. Question: Please
state your agreement regarding smoking restrictions
in the following settings.
Response options to item 1 and 3 were dichotomized
(yes/no). Answers to items 2 and 4 were scored on a
three-point and a four-point scale, depending on the con-
tents; answer categories and re-codification is shown in
data analysis and Results sections (see tables).
Data analysis
Categorical variables are presented as absolute and relative
frequencies with 95% CI, while quantitative variables are
presented as mean and standard deviation (SD). Bivariable
analyses were conducted using chi-square, McNemar, and
Man-Whitney tests, and crude odds ratio (OR) where suit-
able. All associations between variables of interest were
tested. Statistical analyses were conducted using SPSS-19
statistical software. A two-sided p value < 0.05 was consid-
ered to be statistically significant. Multiple logistic regres-
sion analysis (MLR) was conducted to investigate factors
associated with training needs awareness (1-yes/0-no),
participation in TC activities (1-yes/0-no) and strong sup-
port for SFPs (1-strongly agree/0-others). Never smokers
and ex-smokers were aggregated as non-smokers. The fol-
lowing independent variables were tested in the bivariable
analysis and included in the MLR-models: gender (male/
female), age (<45/≥45 years), specialty (GPs/hospitalists),
GT/UGT attendance (1-yes/0-no); RM attitudes as non-
smokers (1-most positive/0-others), SHS beliefs (SHS is
the major indoor pollutant: 1-strongly agree/0-others;
ventilation is effective for eliminating SHS: 1-strongly
disagree; disagree/0- others); smoking behaviour (smokers/
non-smokers) and having a smoke-free home/car (allowing
smoking in the home/car: 0-yes/1-no). A backwards
stepwise procedure was set at the 0.05 significance level.Results were presented as adjusted ORs (aORs) with
95% CIs.
Results
Response rate and socio-demographics
Overall response rate was 63.7%: 605/950. Of the par-
ticipants, 62.6% (379) were female; 58.3% (353) GPs,
32.4% (196) hospitalists, and 9.3% (56) medical students
and recent graduates; mean age was 39.0 ± 12.9 years
(range: 21–70). Hospitalists include 3 main specialities:
internal medicine (n = 90);, neurology (n = 54); rehabili-
tation medicine and others (n = 52). GPs were signifi-
cantly older than hospitalists (mean age ± SD: 42.1 ±
12.6 versus 37.7 ± 12.2 years; p < 0.001).
Smoking behaviour and smoking restrictions in private
settings
Smoking behaviour trends were analysed elsewhere [19].
Smoking prevalence was 29.2% (CI: 23.3-35.1) in males;
and 15.8% (CI: 12.1-19.5) in females, p < 0.001. Current
smoking was similar among GPs, hospitalists and SRGs
[19]. Of the smokers, 52.4% (95% CI: 43.7-61.1) admitted
smoking in the home and 46.8% (95% CI: 38.1-55.5) in
the car (26.2% did not answer). Smoking restrictions in
the home were significantly less reported than in the car:
76.5% (95% CI: 73.12-79.88) versus 84.0% (95% CI: 81.08-
86.92); p < 0.001; (2.8% and 3.1% respectively did not
answer).
Training in smoking prevention/cessation
Participants’ attendance at UGT or GT is shown in
Table 1. The great majority of physicians reported little or
no UGT, particularly the older ones. Of those who re-
ported UGT, 56.6% (95% CI: 49.2-63.9) have received less
than 5 hours; 15.0% (95% CI: 9.7-20.3) more than 12 hours
(not shown). About half of GPs reported GT, contrasting
with hospitalists. Of those participants reporting GT,
40.6% (95% CI: 34.4-46.8) received less than 5 hours;
29.5% (95% CI: 23.8-35.2) more than 12 hours (not
shown). Awareness of training needs was more frequently
reported by GPs, non-smokers, under-45s, those report-
ing GT and females (Table 1). Workplace training pro-
grammes were reported more often by GPs than
hospitalists (OR: 3.6; 95% CI: 2.4-5.4; p < 0.001) (not
shown).
Tobacco control activities
Table 2 presents physicians’ participation in TC activities.
Of the responders, around 9.0% reported participating
regularly in TC activities [smoking prevention: n = 53
(8.8%; CI: 6.5-11.1%); smoking cessation: n = 33 (5.5%, CI:
3.3-6.7%)]. GPs reported being involved in TC more often
than hospitalists, p < 0.001. Participation in TC activities
Table 1 Tobacco control training attendance; awareness of training needs and associated factors
Training Yes n(%) 95% CI No n(%) 95% CI Miss n(%) Total(n) p value Crude OR 95% CI p value
UGT <45 ys 155(42.0) 37.0-47.0 212(57.5) 54.5-64.5 2(0.5) 369 UGT
UGT ≥45 ys 18(7.6) 4.2-11.0 217(91.9) 88.4-95.4 1(0.4) 236 8.8 5.2-14.8 <0.001
UGT Overall 173(28.6) 25.0-32.0 429(70.9) 67.3-74.5 3(0.5) 605 <0.001 Refer: ≥45 ys
GT-GPs 188(53.3) 48.1-58.5 164(46.5) 41.3-51.7 1(0.3) 353 GT
GT-Hs 42(21.4) 15.7-27.1 152(77.6) 71.8-83.4 2(1.0) 196 4.2 2.8-6.2 <0.001
GT-overall 230(41.9) 37.8-46.0 316(57.6) 53.5-61.7 3(0.5) 549 <0.001 Refer: Hs
Training Awareness Yes n(%) 95% CI No n(%) 95% CI Miss n(%) Total(n) Ass factors aOR 95% CI P value
GPs 239(67.7) 62.8-72.6 112(31.7) 26.9-36.6 2(0.6) 353 GP 4.2 2.7-6.6 <0.001
Hs 87(44.4) 37.4-51.4 101(51.5) 44.5-58.5 8(4.1) 196 Non-smoker 2.7 1.7-4.3 <0.001
SRGs 39(69.6) 57.6-81.7 17(30.4) 18.4-42.5 0(0) 56 <45 ys 2.3 1.5-3.4 <0.001
Overall 365(60.3) 56.4-64.2 230(38.0) 34.1-41.9 10(1.7) 605 GT 2.0 1.3-3.0 0.001
Female 1.5 1.0-2.2 0.035
Ass: associate; CI: confidence interval; GPs: General practitioners; GT/UGT: graduate/undergraduate training; Hs: Hospitalists; miss: missing values; OR: odds ratio;
SRG: medical students/recent graduates; ys: years; aOR: OR adjusted for gender, age (<45/≥45 years), specialty (GP/Hs), smoking behaviour (smoker/non-smoker),
GT/UGT (yes/no) and RM attitudes (most positive/others).
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titudes, being a GP or under 45 (see Table 2).
Tobacco control beliefs
Table 3 depicts awareness of the TC law; perception of
compliance with SFP; and SFP/SHS beliefs; contrasting
smokers with non-smokers. Most physicians strongly
agreed that SHS is harmful (88.8%), although only half
strongly reported being the major indoor pollutant
(51.2%), p < 0.001; about half totally agreed that SFPs
could reduce tobacco consumption (52.5%) and disease
burden (52.9%), p < 0.001; over 1/3 were fully aware of
the TC law (35.9%), p < 0.001; in addition, 35.5%, p <
0.001, totally agreed that SFPs could help smokers to
quit; and 33.7% believed that SHS could be eliminated
by ventilation. Smokers believed more often that ventila-
tion could eliminate SHS and were less likely to report
low compliance with the ban. Reporting favourable RMTable 2 Prevention and cessation activities participation and
Prevention/TC Yes n; % 95% CI No n; % 95% CI Total Ass fa
GPs 200; 56.7 51.5-61.9 153; 43.3 38.1-48.5 353 GT
Hs 45; 23.2 17.3-29.1 149; 76.8 70.9-82.7 194 GP
SRGs 19; 34.5 21.9-47.1 36; 65.5 52.9-78.1 55 RM
Total 264; 43.9 39.9-47.9 388; 56.1 52.1-60.1 602
Cessation Yes n; % 95% CI No n; % 95%CI Total Ass fa
GPs 150; 42.5 37.3-47.7 203; 57.5 52.3-62.7 353 GT
Hs 27; 13.9 9.0-18.8 167; 86.1 81.7-91.3 194 GP
SRG 19; 34.5 21.9-47.1 36; 65.5 52.9-78.1 55 ≤45 yr
Total 196; 32.6 28.9-36.3 406; 67.4 63.7-71.1 602 RM
Ass: associated; CI: confidence interval; GPs: General practitioners; GT/UGT: graduate
regression; OR: odds ratio; RM: attitudes to being role model as a non-smoker; SRG: m
gender, age (<45 ys/≥45 ys), specialty (GP/Hs), smoking behaviour (smoker/non-smokattitudes or extensive GT (>5 hours) and being a non-
smoker (Tables 2 and 3) or female were significantly and
positively associated with some TC beliefs, but not all
(not shown).
SFP support
Table 4 depicts support for SFP in public settings by smok-
ing behaviour. Strong support for SFP were reported, re-
spectively in healthcare premises (94.7%), schools (94.4%),
public administration buildings (91.4%), and workplaces
(89.9%); but significantly less support was observed in leis-
ure settings such as restaurants (70.2%), shopping malls
(64.1%), and bars and discos (55.0%), p < 0.001. In addition,
strong support for outdoors bans was lower, respectively in
healthcare settings (58.7%) and schools (52.6%), p < 0.001.
Being a non-smoker was significantly associated with
stronger support for SFP in all settings, with exception of
healthcare indoors. Table 5 shows factors associated withassociated factors (N = 602)*
ctors OR; 95% CI p value aOR;95% CI p value MLR model
6.0; 4.2-8.7 <0.001 5.0; 3.4-7.5 <0.001 72.4%; p < 0.001
4.3; 2.9-6.4 <0.001 2.8; 1.8-4.3 <0.001
1.7; 1.2-2.4 0.001 1.6; 1.1-2.4 0.014
ctors OR; 95% CI p value aOR;95% CI p value MLR model
4.3; 3.0-6.2 <0.001 4.1; 2.7-6.2 <0.001 73.1%; p < 0.001
4.6; 2.9-7.3 <0.001 3.8; 2.3-6.3 <0.001
s 1.3; 0.9-1.8 0.180 2.2; 1.4-3.4 <0.001
1.9; 1.3-2.6 <0.001 1.8; 1.2-2.6 0.007
/undergraduate TC training; Hs: Hospitalists; yrs: years; MLR: multiple logistic
edical students/recent graduates; TC: tobacco control; aOR: OR adjusted for
er), receipt of GT/UG (yes/no) and RM (most positive/others). *3 (0.5%) missing.
Table 3 Second-hand smoke and smoke-free policy beliefs by smoking behaviour
Totally agree Partially agree Disagree
SFP beliefs NS Smokers NS Smokers NS Smokers p-value OR; 95% CI Total; miss
Comprehensive SFP: n (%) n (%) n (%) n (%) n (%) n (%) N;n (%)
Helps smokers reduce consumption 250 (52.2) 65 (51.6) 196 (40.9) 50 (39.7) 16 (3.3) 8 (6.3) 0.318 585; 20 (3.3)
Helps smokers quit 173 (36.1) 42 (33.3) 221 (46.1) 57 (45.2) 71 (14.8) 22 (17.5) 0.712 586; 19 (3.1)
Reduces TR disease/mortality 255 (53.2) 65 (51.6) 189 (39.5) 44 (34.9) 26 (5.4) 13 (10.3) 0.116 592,13 (2.1)
I am aware of SFP law 151 (31.5) 66 (52.4) 290 (60.5) 54 (42.9) 3 (2.4) 6.3 (5.5) <0.001 594; 11 (1.8)
Current SFP is being complied with 80 (16.7) 32 (25.4) 302 (63.0) 64 (50.8) 84 (17.5) 27 (21.4) 0.025 0.59; 0.37-0.94* 589; 16 (2.6)
Strongly agree Agree Disagree Strongly dis
SHS beliefs Non-smokers Smokers Non-smokers Smokers Non-smokers Smokers Non-smokers Smokers OR; 95% CI; p-value Total;miss
SHS: n (%) n(%) n (%) n (%) n (%) n (%) n (%) n (%) N;n (%)
Endangers health 436 (91.0) 101(80.2) 38 (7.9) 24 (19.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2.73; 1.57-4.75* 599; 6 (1.0)
p < 0.001
Is the major indoor pollutant 257 (53.7) 53 (42.1) 209 (43.6) 61 (48.4) 10 (2.1) 7 (5.6) 0 (0.0) 1 (0.8) 1.53; 1.022.28* 598; 7 (1.2)
p = 0.037
Ventilation is effective for eliminating SHS 21 (4.4) 10(7.9) 123 (25.7) 50 (39.7) 256 (53.4) 55 (43.7) 69 (14.4) 9 (7.1) 0.47; 0.32-0.71* 593; 12 (2.0)
p < 0.001
CI: Confidence intervals; NS: non-smokers; OR: crude odds ratio; SHS: second-hand smoke; SFP: smoke-free policy. TR: tobacco-related. *Reference: smokers.
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Table 4 Support for comprehensive smoke-free policies in public settings by smoking behaviour
Suport Strongly agree Agree Disagree Strongly disagree Total Missings Statistical tests
Non-smokers Smokers Non-smokers Smokers Non-smokers Smokers Non-smokers Smokers N
Settings n; % n; % OR*; 95% CI p-value* n; % n; % n; % n; % n; % n; % n; % McNemar p-value
Wplaces 447; 93.3 97; 77.0 4.61; 2.59-8.21 p < 0.001 25; 5.2 23; 18.3 1; 0.2 3; 2.4 1; 0.2 1; 08 598 7;1.2 0.345
Public adm 450; 93.9 103; 81.7 3.36; 1.81-6.25 p < 0.001 24; 5.0 19; 15.1 1; 0.2 1; 0.8 1; 0.2 0; 0.0 599 6; 1.0 Refer
Health I 458; 95.6 115; 91.3 2.00; 0.91-4.37 p = 0.081 15; 3.1 5; 4.0 2; 0.4 3; 2.4 3; 0.6 2; 1.6 603 2; 0.3 0.009
Health O 312; 65.1 43; 34.1 3.45; 2.27-5.24 p < 0.001 101; 21.1 29; 23.0 60; 12.5 37; 29.4 3; 0.6 12; 9.5 597 8; 1.3 <0.001
School I 459; 95.8 112; 88.9 2.89; 1.34-6.23 p = 0.005 14; 2.9 10; 7.9 1; 0.2 2; 1.6 2; 0.4 0; 0.0 600 5; 0.8 <0.001
School O 274; 57.2 44; 34.9 2.47; 1.63-3.72 p < 0.001 108; 22.5 24; 19.0 77; 16.1 39; 31.0 12; 2.5 15; 11.9 593 12; 2.0 <0.001
Rest 371; 77.5 54; 42.9 4.54; 2.98-6.89 p < 0.001 88; 18.4 42; 33.3 14; 2.9 24; 19.0 1; 0.2 2; 1.6 596 9; 1.5 <0.001
Bars/Disc 297; 62.0 36; 28.6 4.06; 2.64-6.24 p < 0.001 140; 29.2 38; 30.2 35; 7.3 39; 31.0 2; 0.4 10; 7.9 597 8; 1.3 <0.001
Shopping malls 329; 68.7 59; 46.8 2.41; 1.61-3.61 p < 0.001 130; 27.1 48; 38.1 16; 3.3 13; 10.3 2; 0.4 3; 2.4 600 5; 0.8 <0.001
95% CI: 95% confidence intervals; Disc: Discos; I: indoors; *OR: crude odds ratio (regarding strongly agree against the others category responses, reference: smokers); O: outdoors; Public adm: public administrations
buildings; Refer: Reference category for comparison (McNemar test); Rest: restaurants; Wplaces: Workplaces. Non-smokers: never-smokers + ex-smokers.
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Table 5 Factors associated with strong support for comprehensive smoke-free policy in public settings
Settings Workplaces Public adm Healthcare I Healthcare O Schools I Schools O Restaurants Bars/discos Malls
Ass factors OR; 95% CI
p-value
OR; 95% CI
p-value
OR; 95% CI
p-value
OR; 95% CI
p-value
OR; 95% CI
p-value
OR; 95% CI
p-value
OR; 95% CI
p-value
OR; 95% CI
p-value
OR; 95% CI
p-value
Non-smoker 2.1; 1.1-4.1
p = 0.032
- - 2.2; 1.4-3.5
p = 0.001
- 1.7; 1.1-2.8
p = 0.031
2.6; 1.6-4.2
p < 0.001
2.6; 1.6-4.1
p < 0.001
-
SF Home 3.6; 1.8-6.9
p < 0.001
2.8; 1.4-5.5
p = 0.003
3.3; 1.5-7.2
p = 0.003
2.9; 1.9-4.6
p < 0.001
2.7; 1.2-6.2
p = 0.021
2.1; 1.3-3.4
p = 0.002
3.1; 1.9-4.9
p < 0.001
2.5; 1.6-3.9
p < 0.001
2.4; 1.5-3.7
p < 0.001
RM attitudes 6.0; 2.3-15.9
p < 0.001
2.2; 1.0-4.7
p = 0.045
- 2.3; 1.6-3.3
p < 0.001
7.3; 1.7-32.1
p = 0.008
2.0; 1.3-2.9
p = 0.001
1.8; 1.2-2.8
p = 0.006
1.7; 1.2-2.5
p = 0.005
1.9; 1.3-2.8
p = 0.001
SHS-Pollutant 2.4; 1.2-4.9
p = 0.015
3.8; 1.7-8.2
p = 0.001
2.5; 1.1-5.9
p = 0.035
- 5.0; 1.6-15.1
p = 0.005
1.9; 1.3-2.8
p < 0.001
1.7; 1.1-2.6
p = 0.012
1.5; 1.0-2.1
p = 0.030
1.7; 1.2-2.4
p = 0.007
SHS Ventilation - 2.1; 1.1-4.1
p = 0.026
- 1.6; 1.1-2.3
p = 0.016
- - 1.8; 1.2-2.7
p = 0.007
1.6; 1.1-2.4
p = 0.011
1.9; 1.3-2.7
p = 0.001
G Training 2.7; 1.3-5.7
p = 0.010
2.1; 1.0-4.5
p = 0.051
- - 3.3; 1.2-9.3
p = 0.026
- - - -
UG Training - - 5.1; 1.2;22.1
p = 0.028
- 5.0; 1.1;22.1
p = 0.034
- - - -
Female 2.4; 1.2-4.6
p = 0.010
- - - 2.9; 1.2-6.7
p = 0.015
- - - -
Being a GP 1.7;1.1-2.4 p = 0.011
Adm: administration; ass: associated; CI: confidence interval; G:graduate; I: indoors; O: outdoors; RM: role model; SHS- second-hand smoke; SF-smoke-free; UG: undergraduate; aOR: adjusted OR for age, gender, specialty,
smoking behavior, SF car, SF home, SHS believes, RM attitudes to being non-smokers, undergraduate/graduate training.
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http://www.biomedcentral.com/1471-2458/14/979strong support for comprehensive SFPs in public settings.
Reporting a smoke-free home was the most consistent
predictor of strong agreement with SFPs, followed by
reporting SHS beliefs, favourable RM attitudes and be-
ing a non-smoker. Smoking behaviour was one of the
main predictors of SFP support within restaurants and
bars/discos, healthcare outdoors (Table 5); and smoking
restrictions in the home/car (not shown).
Discussion
This exploratory study suggests that few Portuguese phy-
sicians are engaged in tobacco control. While the over-
whelming majority strongly agree that SHS endangers
health, strong awareness of SFP public health benefits and
the current TC law is limited; a significant minority be-
lieves that SHS can be eliminated by ventilation systems.
Furthermore, most physicians lacked specific TC training
and only a minority participated regularly in smoking pre-
vention or cessation activities. General agreement with
SFPs was high, but significantly lower for indoor leisure
settings, outdoors bans and private smoking restrictions.
Moreover, participants reported high smoking rates.
Among smokers, smoking in the home or car was com-
mon. GPs were more involved in TC activities, including
training, than hospitalists. Younger physicians reported
UGT more often and being more aware of training needs
than the older ones; they also reported participating more
often in cessation activities. Among physicians, 2/3
recognize that they should receive training on TC, but less
than 1/3 received undergraduate training and less than
half reported graduate training. Training was the most
consistent predictor of participation in TC activities,
followed by being a GP. As underscored by other authors
[16,17,25-31], these findings highlight the need for en-
gaging medical and professional continuous education, as
well as medical associations, with TC; and to disseminate
TC training both in medical schools, and in primary care
and hospital settings. Recently, Do and Bautista have sur-
veyed TC attitudes among a world-wide large sample of
medical students. They have observed that only 25% of
students have received undergraduate training on TC [30].
On the other hand, two recent national surveys have ob-
served that around half of the Portuguese GPs and a mi-
nority (4.9%) of hospitalists have received graduate
training in TC; only a minority of physicians have received
extensive GT or participate in cessation programmes
[17,18]. Whereas physicians receive special training to
provide effective and safe health care to populations, there
is a need for specific training on smoking cessation to
guarantee systematic and effective cessation counselling
and support [21,25]. Similarly, specific TC training is cru-
cial to engage physicians and other HCPs in advocacy and
policy-making [10,11,28,30]. It is also worth noting that
training influenced few items in SFP support and SHS/SFP beliefs, suggesting that those concerned received in-
adequate training on TC policy. This finding also has been
reported by several authors, both nationally and inter-
nationally [16,17,28,30]. In fact, following the preparation
of Portugal’s TC law, HCPs’ training and engagement in
smoking cessation expanded to different healthcare set-
tings. Nevertheless, training and awareness of TC policy
and capacity building are seldom included in these pro-
grammes [32]. When comparing physicians’ overall sup-
port in public settings, acceptance was significantly higher
where the ban is long-standing and has fewer exemptions;
and also for role-model professional workplaces, i.e.
healthcare and school settings. These findings are consist-
ent with past research that has concluded that support is
stronger where bans have been implemented for a longer
time and where there are fewer exemptions [33,34]; and
that additionally, workplaces rules and beliefs influence
support for SFP [35]. Furthermore, cross-country research
has consistently shown that smoke-free bars and pubs are
significantly less well accepted than smoke-free work-
places and restaurants [36]. This same trend was observed
in this study; moreover, physicians reported slightly less
support for smoke-free restaurants and bars than the gen-
eral population [36]. Likewise, a recent wide cross-country
survey has observed that European medical students were
among those reporting less favourable attitudes regarding
smoking bans in restaurants and bars [30]. It should be
emphasized that since there is no safe level of SHS expos-
ure, strong SFP support should apply for all settings.
These findings clearly indicate that physicians are not par-
ticularly aware of public health science or more specific-
ally of the fact that only comprehensive SFPs protect
populations against SHS. Moreover, the great majority of
physicians reported low compliance with the partial ban;
suggesting that they should be more aware of the need for
a comprehensive policy. Factors associated with stronger
support for SFPs followed the same pattern as for general
population. Being a non-smoker strongly predicted sup-
port for smoking restrictions in outdoors, leisure and pri-
vate settings. These settings were, in turn, those with
lower physicians’ support. As reported by other studies
[16,17,28,37,38], these findings clearly indicate that smok-
ing among physicians is still a major barrier to social norm
change. On the other hand, reporting a smoke-free home
was the most consistent factor associated with strong SFP
support. In fact, regulation of smoking in the home is a
strong predictor of self-enforcement and compliance with
SFPs and social norm change, even among smokers
[39,40]. Furthermore, younger physicians did not consist-
ently report stronger support for SFPs, which may suggest
that they are not trained on TC policy and that the social
norm did not change after the implementation of the par-
tial ban. In sum, all these findings suggest that physicians’
attitudes to SFP are not influenced by evidence-based
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studies [16,17,28]. Physicians’ attitudes and behaviours do,
however, clearly influence their clinical and public health
practice [12,20,26,27]. In Portugal, the great majority of
physicians are not active in leading public health policy
and TC advocacy. The Portuguese Medical Association
is not engaged in tobacco control; an official policy on
tobacco use and advocacy is lacking [41,42]. Mean-
while, many HCPs and physicians continue to smoke
[15,16,19,32]. When physicians are noticed smoking in
public, this reinforces smoking visibility and social accept-
ance, undermining social norm change [16,19,29]. In
addition, smoking physicians are less likely to provide ces-
sation support or to actively advocate for tobacco control
policies [30]. By contrast, when smoking physicians and
HCPs are enrolled in a cessation programme, this pro-
motes their advice on tobacco cessation [43]. Similarly,
physicians’ training in TC is associated to willingness to
quit [19]. Thus to promote tobacco control, especially
in countries where tobacco use is prevalent among
HCPs, it is crucial to implement cessation programmes
targeting medical/health sciences students, physicians and
other healthcare workers, both in medical/health sciences
schools and healthcare settings [16,19,28-31,44]. These
programmes should be funded and evidence-based; they
should be linked to comprehensive TC training focusing
on tobacco health hazards, the role of physicians/HCPs in
TC, policy and capacity building and not only tobacco ces-
sation skills. An effective health promotion/TC national
strategy should prioritise comprehensive, integrated and
adequately-funded TC programmes led by TC experts and
actively engaging medical/health sciences schools, medical
associations and HCPs networks/societies, hospital man-
agers and healthcare systems [10,16,19,28-31,44-47].
These programmes have a key role to play, and should
contemplate the following:
 Promote and enforce SFPs, including smoke-free
university/hospital campus;
 Disseminate TC training among HCPs, emphasising
the key role of HCPs and physicians as non-smoking
exemplars and TC advocates;
 Strengthen participation of and partnership with
non-governmental organisations and civil society
 Raise public awareness regarding tobacco addiction,
tobacco use and SHS health hazards, and the
benefits of tobacco cessation
 Promote and adequately support smoking cessation
[10,46].
Strengths and limitations
This study has both strengths and limitations. The main
limitation includes the non-random selection of physi-
cians who have attended two national conferences; andthe low sample size when considering medical specialties
sub-groups. This affects the representativeness and gen-
eralisability of the study findings. Thus sample selections
bias should be stressed. Nevertheless, the target popula-
tion is difficult to survey, especially in Portugal. On the
other hand, it is particularly challenging to obtain a rep-
resentative sample of physicians including the different
specialties and healthcare settings. Nationwide physi-
cians’ databases were not available when the study was
planned. Conference surveys with high response rates
and low sample selection bias are described in the litera-
ture [20]. Attendees of national medical associations’
conferences are usually representative of their members;
these scientific events bring together physicians from all
over the country with a wide range of age and profes-
sional development [20]. This justifies the study design.
However, whereas attendees of national medical asso-
ciations’ conferences are usually representative of their
members, they are not representative of the whole popu-
lation of Portuguese physicians. In particular, these two
conferences targeted only GPs and hospitalists, mainly
neurologists, internal medicine and rehabilitation medi-
cine doctors. Theoretically, physicians attending medical
conferences would be those more motivated to or in-
volved in research and education. However in Portugal,
medical conferences are highly sponsored by the
pharmaceutical industry, which in turn tends to invite
clinicians more engaged with pharmaceutical prescrip-
tion. We may consider that these physicians are less in-
volved with public health. Nevertheless, WHO clearly
emphasises that all healthcare providers and specially
physicians should be engaged with smoking cessation
and TC [10]. On the other hand, because of the study’s
cross-sectional design, causality cannot be established.
The study relies on self-reported responses, thus social
desirability bias should be stressed. Given the response
rate, non-response bias should be allowed. Furthermore,
responders generally include those more interested in
the subject. Thus, it should be assumed that physicians’
tobacco use is underestimated, and that physicians’ in-
volvement in TC is probably even more limited. In spite
of these limitations, this survey is one of the few that ex-
plored physicians’ involvement in TC in Portugal and
obtained good response rates. When compared with na-
tional and international surveys similar trends were ob-
served. Finally, the good response rate suggests that a
well-planned conference-based survey may be an in-
novative and good approach to survey physicians in
countries where this is particularly difficult.
Conclusions
The findings suggest that Portuguese physicians are not
aware of their role in tobacco control. Furthermore, phy-
sicians’ smoking prevalence is high. This highlights the
Ravara et al. BMC Public Health 2014, 14:979 Page 10 of 11
http://www.biomedcentral.com/1471-2458/14/979need for engaging medical schools and medical profes-
sional organisations with tobacco control and physicians’
smoking prevention. Poor engagement of physicians in
tobacco control may contribute to the current lack of
comprehensive policies in Portugal and Europe, and
undermine social norm change. Medical associations/or-
ganisations should acknowledge their leadership role
and assume a core responsibility in promoting smoke-
free environments and tobacco control best practices.
To achieve this, medical and continuing education on
tobacco control should be made top priorities. Training
should be adequately-funded, led by TC experts and in-
clude tobacco health hazards, emphasis on the role of
physicians in TC, capacity building, benefits of tobacco
cessation and cessation skills.
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